Literature DB >> 891025

Acute hepatitis: significance of changes in complement components.

J A Charlesworth, S Lawrence, P A Worsdall, L P Roy, C R Boughton.   

Abstract

Serial measurements of complement components were performed in fifty-nine patients with acute, uncomplicated hepatitis and twelve with alcoholic cirrhosis. Thirty-one of the former group had detectable hepatitis B antigen. Abnormal complement profiles were observed in nine patients with hepatitis B and seven with antigen-negative hepatitis. Low levels of C4, C3 and factor B were common in the subjects with cirrhosis and confined to those cases with severe reduction in serum albumin and/or prothrombin index. By contrast, the complement changes in the patients with hepatitis occurred without significant alteration in these parameters; certain subjects also had reduction in C1q and C5 and a significant number had C3d detectable in fresh plasma. The pattern of abnormality suggests predominant involvement of the classical pathway and it is concluded that this results, at least in part, from an immune process evident only in the early clinical phase of hepatitis. Such gross changes in complement are likely to reflect immune-complex activity and it is proposed that these complexes may be important in the clearance of virus material. The data supports a previous suggestion that recovery from acute hepatitis is primarily dependent on host immune competence rather than viral cytotoxicity or generation of immune complexes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 891025      PMCID: PMC1541000     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.

Authors:  C B LAURELL
Journal:  Anal Biochem       Date:  1965-02       Impact factor: 3.365

2.  Measles infection. Involvement of the complement system.

Authors:  J A Charlesworth; B A Pussell; L P Roy; M R Robertson; J Beveridge
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

3.  Immunity deficiency in pathogenesis of glomerulonephritis.

Authors:  D K Peters; P J Lachmann
Journal:  Lancet       Date:  1974-01-12       Impact factor: 79.321

4.  Antibody to hepatitis-B-virus core in man.

Authors:  J H Hoofnagle; R J Gerety; L F Barker
Journal:  Lancet       Date:  1973-10-20       Impact factor: 79.321

5.  Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen.

Authors:  V Giustino; F J Dudley; S Sherlock
Journal:  Lancet       Date:  1972-10-21       Impact factor: 79.321

6.  Variable mechanisms for low serum-complement in liver disease.

Authors:  L D Petz
Journal:  Lancet       Date:  1971-11       Impact factor: 79.321

7.  Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation.

Authors:  N R Shulman; L F Barker
Journal:  Science       Date:  1969-07-18       Impact factor: 47.728

8.  Immune complexes in hepatitis.

Authors:  J D Almeida; A P Waterson
Journal:  Lancet       Date:  1969-11-08       Impact factor: 79.321

9.  Lymphocyte transformation and leucocyte migration-inhibition by Australia antigen.

Authors:  A A Laiwah; A K Chaudhuri; J R Anderson
Journal:  Clin Exp Immunol       Date:  1973-09       Impact factor: 4.330

10.  Studies of serum complement in the hypocomplementaemic nephritides.

Authors:  D G Williams; D K Peters; J Fallows; A Petrie; O Kourilsky; L Morel-Maroger; J S Cameron
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

View more
  7 in total

1.  Paediatric Research Society. Plymouth, 15 and 16 September 1978: Abstracts.

Authors: 
Journal:  Arch Dis Child       Date:  1979-02       Impact factor: 3.791

Review 2.  Problems of bacterial infection in patients with liver disease.

Authors:  R J Wyke
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

Review 3.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

4.  Circulating immune complexes and complement concentrations in patients with alcoholic liver disease.

Authors:  C Gluud; H Jans
Journal:  J Clin Pathol       Date:  1982-04       Impact factor: 3.411

5.  Defective opsonisation and complement deficiency in serum from patients with fulminant hepatic failure.

Authors:  R J Wyke; I A Rajkovic; A L Eddleston; R Williams
Journal:  Gut       Date:  1980-08       Impact factor: 23.059

6.  Studies on circulating immune complexes of the liver disease. 4. Clq binding activity.

Authors:  T Arima; J Narumoto; H Shimomura; K Suwaki; K Kunishi; T Yasuhara; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1980

7.  Complement levels in patients with hepatic dysfunction.

Authors:  R T Ellison; C R Horsburgh; J Curd
Journal:  Dig Dis Sci       Date:  1990-02       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.